Utilization of Systemic Chemotherapy in Advanced Urothelial Cancer: A Retrospective Collaborative Study by the Hellenic Genitourinary Cancer Group (HGUCG)

Micro-Abstract Advanced urothelial cancer (AUCa) is associated with poor long-term survival due to nonexposure to cisplatin-based chemotherapy and poor outcome after relapse. This study records the patterns of practice in AUCa, focusing on first-line treatment and management of relapsed disease.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical genitourinary cancer 2016-04, Vol.14 (2), p.e153-e159
Hauptverfasser:	Bamias, Aristotle, Peroukidis, Stavros, Stamatopoulou, Sophia, Tzannis, Kimon, Koutsoukos, Konstantinos, Andreadis, Charalambos, Bozionelou, Vasiliki, Pistalmatzian, Nikos, Papatsoris, Athanasios, Stravodimos, Konstantinos, Varthalitis, Ioannis, Karamouzis, Michalis, Milaki, Georgia, Agorastos, Antonios, Kentepozidis, Nikos, Androulakis, Nikos, Bompolaki, Iliada, Kalofonos, Haralampos, Mavroudis, Dimitrios, Dimopoulos, Meletios A
Format:	Artikel
Sprache:	eng
Schlagworte:	Advanced urothelial cancer Aged Aged, 80 and over Antineoplastic Combined Chemotherapy Protocols - therapeutic use Cisplatin - therapeutic use Female Fitness for cisplatin Greece Hematology, Oncology and Palliative Medicine Humans Male Middle Aged Patterns of practice Prognosis Recurrence Retrospective Studies Risk Factors Survival Analysis Treatment Outcome Urologic Neoplasms - drug therapy Urologic Neoplasms - pathology Urology Urothelium - pathology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Micro-Abstract Advanced urothelial cancer (AUCa) is associated with poor long-term survival due to nonexposure to cisplatin-based chemotherapy and poor outcome after relapse. This study records the patterns of practice in AUCa, focusing on first-line treatment and management of relapsed disease.
ISSN:	1558-7673 1938-0682
DOI:	10.1016/j.clgc.2015.09.009